Sherman Act Cut From Clot Drug Suit, State Claims Survive
A Tennessee federal judge has freed Momenta Pharmaceuticals Inc. and Sandoz Inc. from Sherman Act allegations that they conspired to monopolize the market for the blood clot drug Lovenox and its...To view the full article, register now.
Already a subscriber? Click here to view full article